title: Further evidence for the effectiveness of PCV10 against Streptococcus pneumoniae serotype 19A.
authors.affiliation: GlaxoSmithKline Vaccines, Wavre 1300, Belgium. Electronic address: christopher.j.clarke@gsk.com.
authors.forename: Christopher J P
authors.initials: CJ
authors.lastname: Clarke
authors.affiliation: GlaxoSmithKline Vaccines, Wavre 1300, Belgium.
authors.forename: William P
authors.initials: WP
authors.lastname: Hausdorff
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D011008:Pneumococcal Infections / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000627:therapeutic use*; D013296:Streptococcus pneumoniae / Q000276:immunology*
chemical_list: C586648:10-valent pneumococcal conjugate vaccine; D022242:Pneumococcal Vaccines